Use the Back button in your browser to see the other results of your search or to select another record.
Pulsed electromagnetic field in patients with shoulder impingement syndrome |
Galace de Freitas D, Monteiro RL, Marcondes FB, Fenzl K, Vantin K, Fukuda TY, de Moraes Barros Fucs PM |
The Journal of Applied Research 2013;13(1):28-33 |
clinical trial |
8/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
STUDY: Double-blind, randomized controlled trial. OBJECTIVES: Evaluate the effects of pulsed electromagnetic field (PEMF) in reducing pain, improve function and muscle strength in patients with shoulder impingement syndrome (SIS). INTRODUCTION: Recent studies show that a PEMF based program has been indicated for musculoskeletal disorders. However, there are few clinical studies to evaluate the results of this type of program for SIS. METHODS: Fifty-six patients were recruited, aged between 40 and 59 years, diagnosed with SIS. The participants were divided into two groups: PEMF (n = 26, average age of 50.77 years) and placebo group (n = 30, ages of 50.15 years). The variables UCLA, scale of constant Murley, EVA and internal and external rotation and shoulder elevation muscle strength were used. RESULTS: At the end of treatment, both groups showed improvements in all outcome measures in relation to baseline values. Changes over time at UCLA, Constant-Murley and EVA were not different between PEMF and placebo group. CONCLUSION: The PEMF was effective in improving the function of the shoulder and pain relief in patients with SIS. There was a slight improvement of pain in both groups, after the application of PEMF and placebo, with no statistically significant difference between the groups, which suggested there was a placebo effect. LEVEL OF EVIDENCE: Therapy, level 1A.
|